Enhanced External Counterpulsation

Definition

Enhanced external counterpulsation (EECP) is a noninvasive procedure in which a set of inflatable cuffs (much like blood pressure cuffs) mechanically compress the blood vessels in the patient's lower limbs to increase blood flow in the coronary arteries of the heart. The blood pressure cuffs are wrapped around the patient's calves, thighs, and buttocks. Computer technology, electrocardiography, and blood pressure monitors enable the accurate timing of gentle but firm inflation and deflation of the pressure cuffs with the patient's heartbeat and blood pressure.


Purpose

EECP is performed to restore blood flow to the heart and to relieve chest pain (angina) and ischemia. The goals of the procedure are to relieve symptoms of coronary artery disease, enable the patient to resume a normal lifestyle, and lower the risk of a heart attack or other heart problems. EECP may encourage blood vessels to open small channels (called collaterals) to eventually bypass blocked vessels and improve blood flow to the heart.


Demographics

The concept of counterpulsation is not new (it was first introduced in the late 1950s at Harvard), but the computerized technology currently available with EECP makes it a relatively new procedure, introduced less than 10 years ago. As of 2003 it is available in only about 200 centers across the United States.

EECP is used to treat patients with chronic stable angina, coronary artery disease, or high blood pressure. Most recently, the Food and Drug Administration (FDA) has approved EECP for the treatment of congestive heart failure. The treatment may be appropriate for patients who are not eligible for such non-surgical interventional procedures as balloon angioplasty, stent placement, rotoblation, atherectomy, or brachytherapy. It may also be used for patients who do not qualify for such surgical treatment as coronary artery bypass graft surgery.

EECP is not the first-line treatment for angina. Rather, it is reserved for patients who have not achieved good results from medication or interventional management of their symptoms.

EECP may benefit patients with such other medical conditions as erectile dysfunction, kidney disease, eye disease, diabetic neuropathy, and other circulatory disorders. More research is needed to evaluate the outcomes of EECP for these patients.

Many insurance providers and Medicare have approved EECP treatment for reimbursement.



Advertisement
Advertisement